EDGAR Filing Documents for 0001972362-23-000707

Form 144 - Report of proposed sale of securities:

SEC Accession No. 0001972362-23-000707

Filing Date

2023-08-25

Accepted

2023-08-25 16:46:33

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	144
1		primary_doc.xml	144	6923
	Complete submission text file	0001972362-23-000707.txt		8378

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412

SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38662 | Film No.: 231209016
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Business Address

Shtylla Brunilda (Reporting) CIK: 0001966915 (see all company filings)

Type: 144